Viva BioInnovator is a venture capital firm that globally invests in early-stage biotech innovation, focusing on novel solutions for unmet medical needs across biopharmaceuticals, medical devices, diagnostics, and life science tools. Their strategy involves providing both financial investment and in-kind services, leveraging Viva Biotech's R&D expertise to accelerate the growth of their portfolio companies.
Portfolio
2
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 DTx Pharma | Series B | $100M | Mar 2021 |
 Iterion Therapeutics | Series B | $17M | Feb 2021 |
Top Co-Investors
GPG Ventures1 shared
RA Capital Management1 shared
Access Biotechnology1 shared
Surveyor Capital1 shared
Cormorant Asset Management1 shared
Janus Henderson Investors1 shared
Logos Capital1 shared
Eli Lilly and Company1 shared
Last updated: 4 March 2026